Biological Drugs Raise Concerns about Their Safety

A group of Dutch researchers have reported that about one fourth of the biological drugs that had hit the United States and Europe markets since 1995 had given rise to concerns about their safety just a few years after they had been approved.

Derived from living cells (and not from various chemicals like the typical drugs are), the biological meds have prompted safety warnings with regards to immune system disorders, infusion reactions, infections and cancer risk.

Read the rest of this entry »

Questions Arise About Scientist’s Involvement With BPA

WASHINGTON— The Food and Drug Administration said Tuesday it will look into concerns that a prominent toxicologist asked to render an independent verdict on a sensitive consumer safety issue may have a financial conflict-of-interest.

But an FDA official said there is no reason to believe that University of Michigan professor Martin Philbert did anything improper. The case involves bisphenol A, a chemical used to make plastics that is found in consumer goods from soup cans to baby bottles, and seen as a health risk by some.

Read the rest of this entry »